Cargando…
Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway
Icariin (ICA) is the main active flavonoid glucoside from herbs of the genus Epimedium; in traditional Chinese medicine, these herbs have long been prescribed for the treatment of bone fractures and osteoporosis. Several studies have shown that treatment with ICA can increase osteogenic differentiat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864436/ https://www.ncbi.nlm.nih.gov/pubmed/31661767 http://dx.doi.org/10.3390/molecules24213875 |
_version_ | 1783471882202251264 |
---|---|
author | Chen, Meng Cui, Yazhou Li, Hui Luan, Jing Zhou, Xiaoyan Han, Jinxiang |
author_facet | Chen, Meng Cui, Yazhou Li, Hui Luan, Jing Zhou, Xiaoyan Han, Jinxiang |
author_sort | Chen, Meng |
collection | PubMed |
description | Icariin (ICA) is the main active flavonoid glucoside from herbs of the genus Epimedium; in traditional Chinese medicine, these herbs have long been prescribed for the treatment of bone fractures and osteoporosis. Several studies have shown that treatment with ICA can increase osteogenic differentiation and reduce bone loss in vivo and in vitro. However, the definite signaling pathway of this osteogenic effect remains unclear. In this study, we selected bone morphogenetic protein 2 (BMP2)-induced osteoblastic differentiation of multipotent mesenchymal progenitor C2C12 cells as a model of osteoblast differentiation. We investigated the effects of ICA on C2C12 cells osteogenic differentiation and the underlying molecular mechanisms. We found that ICA could enhance BMP2-mediated osteoblastic differentiation of C2C12 cells in a dose-dependent manner. Treatment with ICA activated the cAMP/PKA/CREB signaling axis in a time-dependent manner. Blocking cAMP signaling using the PKA selective inhibitor H89 significantly inhibited the stimulatory effect of ICA on osteogenesis. Therefore, the osteoinductive potential and the low cost of ICA indicate that it is a promising alternative treatment or promoter for enhancing the therapeutic effects of BMP2. |
format | Online Article Text |
id | pubmed-6864436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68644362019-12-23 Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway Chen, Meng Cui, Yazhou Li, Hui Luan, Jing Zhou, Xiaoyan Han, Jinxiang Molecules Article Icariin (ICA) is the main active flavonoid glucoside from herbs of the genus Epimedium; in traditional Chinese medicine, these herbs have long been prescribed for the treatment of bone fractures and osteoporosis. Several studies have shown that treatment with ICA can increase osteogenic differentiation and reduce bone loss in vivo and in vitro. However, the definite signaling pathway of this osteogenic effect remains unclear. In this study, we selected bone morphogenetic protein 2 (BMP2)-induced osteoblastic differentiation of multipotent mesenchymal progenitor C2C12 cells as a model of osteoblast differentiation. We investigated the effects of ICA on C2C12 cells osteogenic differentiation and the underlying molecular mechanisms. We found that ICA could enhance BMP2-mediated osteoblastic differentiation of C2C12 cells in a dose-dependent manner. Treatment with ICA activated the cAMP/PKA/CREB signaling axis in a time-dependent manner. Blocking cAMP signaling using the PKA selective inhibitor H89 significantly inhibited the stimulatory effect of ICA on osteogenesis. Therefore, the osteoinductive potential and the low cost of ICA indicate that it is a promising alternative treatment or promoter for enhancing the therapeutic effects of BMP2. MDPI 2019-10-28 /pmc/articles/PMC6864436/ /pubmed/31661767 http://dx.doi.org/10.3390/molecules24213875 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Meng Cui, Yazhou Li, Hui Luan, Jing Zhou, Xiaoyan Han, Jinxiang Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title | Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title_full | Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title_fullStr | Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title_full_unstemmed | Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title_short | Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway |
title_sort | icariin promotes the osteogenic action of bmp2 by activating the camp signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864436/ https://www.ncbi.nlm.nih.gov/pubmed/31661767 http://dx.doi.org/10.3390/molecules24213875 |
work_keys_str_mv | AT chenmeng icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway AT cuiyazhou icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway AT lihui icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway AT luanjing icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway AT zhouxiaoyan icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway AT hanjinxiang icariinpromotestheosteogenicactionofbmp2byactivatingthecampsignalingpathway |